ABOUT    |  NEWS  |  PRODUCTS  |  TECHNOLOGY  |  INVESTOR RELATIONS  |  CAREER  |  PATIENTS

CONTACT

Investor & Public Relations

  Mr. Joerg Petrass

Research & Development

  Dr. Matthias Schroff

Business Development

  Ms. Arlett Killat

NEWS

March 15, 2012

MOLOGEN applies for lung cancer phase II study with MGN1703

 

 the press release

Feb. 21, 2012

MOLOGEN also wins patent protection in Japan for cell-based cancer therapy MGN1601

 

 the press release

 the ad-hoc release

NEWSLETTER

To receive our press releases please

 click here